MyFinsight
Home
Blog
About
Back
Cash Flow
Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. (TTRX)
source: myfinsight.com
Proceeds from avenue
capital loan agreement
$1
Net cash provided by
financing activities
$1
Net increase in cash
and cash...
-$929,161
Canceled cashflow
$1
Net loss from change
in fair value of...
-$3,341,568
Amortization of deferred
offering cost
$638,747
Stock-based compensation
expense
$419,233
Accounts payable and
accrued expenses
$290,487
Amortization of debt discount
$117,608
Prepaids and other
current assets
-$104,355
Amortization expense
$14,531
Net cash used in
operating activities
-$923,364
Net cash used in
investing activities
-$5,798
Canceled cashflow
$4,926,529
Net loss
-$5,849,893
Purchases of intangible
assets
$5,798
Back